Evaluation of N1539 Following Bunionectomy Surgery

NCT02675907 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

201

Enrollment

INDUSTRY

Sponsor class

Conditions

Pain, Post-operative

Interventions

DRUG: N1539
DRUG: Intravenous Placebo

Sponsor

Baudax Bio